American Society of Clinical Oncology

Latest articles

18h
Business Wire
Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenibwith active Hepatitis B virus (HBV) or active Hepatitis C virus (HCV).1,2 Data
Business Wire / Posted 18 hours ago
with active Hepatitis B virus (HBV) or active Hepatitis C virus (HCV).1,2 Data from CheckMate -040 were presented at the American Society of Clinical Oncology 2017 Annual Meeting in June. In the CheckMate -040 trial, 14.3%* (95% CI: 9.2-20.8;... Read more
5 related articles
3d
Bureau County Republican
CGH Medical Center recognized for cancer care standardsCGH Medical Center in Sterling has been recognized by the QOPI Certification Pr
Bureau County Republican / Posted 3 days ago
CGH Medical Center in Sterling has been recognized by the QOPI Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), as successfully completing a three-year certification program for re-certification in outpatient... Read more
5d
ScienceBlogs
IBM Watson: Not living up to hype as a tool to fight cancer?been any peer-reviewed studies on Watson in the medical literature yet, but tha
ScienceBlogs / Posted 5 days ago
been any peer-reviewed studies on Watson in the medical literature yet, but that doesn’t mean there are no data yet. At the American Society of Clinical Oncology (ASCO) meeting this year, there were three abstracts presented reporting the results of... Read more
5d
The Hill
The House should read the fine print on 'Right to Try' billof the country’s largest and most reputable physician and patient advocacy orga
The Hill / Posted 5 days ago
of the country’s largest and most reputable physician and patient advocacy organizations oppose this bill, including the American Society of Clinical Oncology, the Cancer Action Network of the American Cancer Society, the National Organization... Read more
10d
Business Wire
Healthcare Research & Analytics® Presents Patient Centricity: The Role of Wearable Technology in Patients with Chronic Conditions, a Webinar Seriesand tumor progression, at Duke University Medical Center. In addition, Dr. Jone
Business Wire / Posted 10 days ago
and tumor progression, at Duke University Medical Center. In addition, Dr. Jones has served on several groups at the American Society of Clinical Oncology and received great support from health institutions including the U.S Department of... Read more
12d
Newsmax
Powerful New Cancer Treatments Come With Rare Risks for Someyou have to treat a lot of people before you see these really rare ones,” said
Newsmax / Posted 12 days ago
you have to treat a lot of people before you see these really rare ones,” said Bruce Johnson, president of the American Society of Clinical Oncology. Weakened Immune System Patients don’t always tell their doctors when realize... Read more
12d
Business Wire
Zymeworks Presents Additional Safety and Anti-Tumor Activity Data from the Ongoing Phase 1 Study of ZW25 at the European Society for Medical Oncology 2017 Congress (“ESMO”)Takeaways: The expanded dataset includes an additional three-month follow-up f
Business Wire / Posted 12 days ago
Takeaways: The expanded dataset includes an additional three-month follow-up for on-study patients following the American Society of Clinical Oncology (“ASCO”) conference in June 2017, as well as safety data on six new patients. The best... Read more
8 related articles
14d
Business Wire
Auf der Jahrestagung der europäischen Gesellschaft für medizinische Onkologie 2017 vorgestellte neue Daten zeigen, dass Abirateronacetat plus Prednison sowohl beim metastasierten hormonnaiven als auch beim kastrationsresistenten Prostatakarzinom...untermauert, die im Juni im New England Journal of Medicine veröffentlicht sowi
Business Wire / Posted 14 days ago
untermauert, die im Juni im New England Journal of Medicine veröffentlicht sowie auf der Jahrestagung der American Society of Clinical Oncology 2017 vorgestellt wurden und die eine erhebliche Verbesserung des Gesamtüberlebens und... Read more
544 related articles
17d
Channel NewsAsia
Discussing cancer costs can reduce treatment expenseswith patients since they are going to bear some financial burden,” said Dr. Ric
Channel NewsAsia / Posted 17 days ago
with patients since they are going to bear some financial burden,” said Dr. Richard Schilsky, chief medical officer of The American Society of Clinical Oncology (ASCO). “I am hopeful that as doctors read about studies like this they realize that... Read more
17d
AllAfrica.com
The Dangers of E-Cigarettes/Vapingyoungsters, long after they were used. A policy statement by the American Assoc
AllAfrica.com / Posted 17 days ago
youngsters, long after they were used. A policy statement by the American Association for Cancer Research and the American Society of Clinical Oncology has reported that "Third-hand exposure occurs when nicotine and other chemicals from... Read more
23d
FOX News
Cancer patients lack access to fertility supporttreatment either temporarily or permanently affects the fertility potential of
FOX News / Posted 23 days ago
treatment either temporarily or permanently affects the fertility potential of 50 to 75 percent of cancer survivors. The American Society of Clinical Oncology (ASCO) recommends that healthcare providers discuss as early as possible the risk of... Read more
3 related articles
24d
Decclan Chronicle
Cancer patients lack access to fertility support, says studytreatment either temporarily or permanently affects the fertility potential of
Decclan Chronicle / Posted 24 days ago
treatment either temporarily or permanently affects the fertility potential of 50 to 75 percent of cancer survivors. The American Society of Clinical Oncology (ASCO) recommends that healthcare providers discuss as early as possible the risk of... Read more
3 related articles
24d
asianage
Most cancer patients do not have adequate access to fertility support, says studytreatment either temporarily or permanently affects the fertility potential of
asianage / Posted 24 days ago
treatment either temporarily or permanently affects the fertility potential of 50 to 75 percent of cancer survivors. The American Society of Clinical Oncology (ASCO) recommends that healthcare providers discuss as early as possible the risk of... Read more
3 related articles
24d
Channel NewsAsia
Cancer patients lack access to fertility supporttreatment either temporarily or permanently affects the fertility potential of
Channel NewsAsia / Posted 24 days ago
treatment either temporarily or permanently affects the fertility potential of 50 to 75 percent of cancer survivors. The American Society of Clinical Oncology (ASCO) recommends that healthcare providers discuss as early as possible the risk of... Read more
3 related articles
25d
ScienceBlogs
Another front in the libertarian war on the FDA: Rational Vaccines unethical offshore herpes vaccine clinical trialdespite the optics created by the Goldwater Institute were cowed and remained s
ScienceBlogs / Posted 25 days ago
despite the optics created by the Goldwater Institute were cowed and remained silent until very late. For example, the American Society of Clinical Oncology (ASCO), an society to which I belong, spent the last three and a half years saying... Read more
7 related articles
25d
Business Wire
U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemiaendpoint) compared to the rate achieved in patients treated with imatinib. Resu
Business Wire / Posted 25 days ago
endpoint) compared to the rate achieved in patients treated with imatinib. Results from the trial were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in May 2017 and at the European Hematology Association (EHA)... Read more
30d
Business Wire
Astex Pharmaceuticals Celebrates as Cancer Drug Receives Marketing Approval in Europeof first-line ribociclib plus letrozole in hormone receptor-positive HER2-negat
Business Wire / Posted 30 days ago
of first-line ribociclib plus letrozole in hormone receptor-positive HER2-negative advanced breast cancer. Presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), June 4, 2017, Chicago, Illinois (abstract... Read more

In this news